LOGIN
AAOS 2016: IV TXA reduced blood loss in hip arthroplasty for femoral neck fracture
March 2016
AAOS 2016: IV TXA reduced blood loss in hip arthroplasty for femoral neck fracture
Study Type:Therapy
OE Level Evidence:N/A
Journal Level of Evidence:N/A
Tranexamic Acid Safely Reduced Blood Loss: Randomized Clinical Trial of 138 Femoral Neck Fractures
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
Synopsis
138 patients undergoing hip arthroplasty for acute femoral neck fracture were randomized to receive either intravenous tranexamic acid (TXA) or placebo intraoperatively. The purpose of this study was to assess the efficacy of TXA for reducing blood loss and the incidence of blood transfusion, as well as to compare the complication rates between groups at 30- and 90-day follow-up. The results displ...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.